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Autologous nonmyeloablative hematopoietic stem cell
transplantation (AHST) in newly diagnosed and young
adult type 1 diabetes mellitus (T1DM) was reported. We
report our first year AHST experience in newly diag-
nosed childhood T1DM. 7 patients with T1DM (HbA1c
11.7%-14%, 4 with diabetic ketoacidosis, aged 5.0-13.7
years) diagnosed within the previous 3 months by clini-
cal findings and hyperglycemia and confirmed with posi-
tive antibodies against GAD65, IA2, ICA or insulin.
Hematopoietic stem cells were mobilized with cyclopho-
sphamide and granulocyte colonystimulating factor and
then collected from peripheral blood by leukapheresis
and cryopreserved. The cells were injected intravenously
after conditioning with cyclophosphamide and rabbit
antithymocyte globulin. Major side effects, changes in
exogenous insulin requirements, HbA1c, C-peptide
levels are analyzed.
During a 12- to 18-month follow-up, 6 (6/7, 85.7%)
patients became insulin free 1-3 months after AHST,
1 patients failed (5 year old) to acquire insulin free, all the
patients resumed normal school study. The preprandial, pre-
dormital blood glucose were ranged from 3.9-6.0 mmol/L
with the HbA1c level between 4.6%-6.1% in insulin-indepen-
dent patients. Vomiting, anorexia, short-term fever, hair loss
occurred in all the patients during AHST, convulsion
occurred in 1 patients due to severe sodium water retention,
leukocytopenia was evident in the first 1-3 months after
AHST, one patients suffered from acute bronchitis 2 months
after AHST. No other systemic organ lesions were found in
all the patients. High-dose immunosuppression and AHST
were performed with acceptable toxicity in 7 patients with
newly diagnosed childhood T1DM. With AHST, beta cell
function was improved and induced insulin independence in
the majority of the patients.
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